DNMT3A and myeloid sarcoma: Consistent with our analysis, the predicted microglia-specific gene DNMT3A has been recently reported in a scRNA-seq study to be over-expressed in one cluster of microglial cells from MS patients (Fold increase: 1.21, P = 8.37e-08, FDR = 0.0028)36.